Clinical trials
Phase 3 Diabetic Nephropathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 9 |
| Unknown status | 4 |
| Withdrawn | 3 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Tanta University | 3 |
| Alessandro Doria | 2 |
| Daiichi Sankyo Co., Ltd. | 2 |
| Keryx Biopharmaceuticals | 2 |
| Singapore General Hospital | 2 |
| AbbVie | 1 |
| Ain Shams University | 1 |
| Biogen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 40 |
| Diabetes Mellitus, Type 2 | 13 |
| Diabetes Mellitus | 9 |
| Kidney Diseases | 9 |
| Albuminuria | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Hypertension | 4 |
| Kidney Failure, Chronic | 4 |
| Proteinuria | 4 |
| Renal Insufficiency, Chronic | 4 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.